Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
HCV Advocate

Wednesday, May 16, 2012

Ribavirin Helps Early Hepatitis C Treatment in People with HIV

Adding ribavirin to pegylated interferon increases the likelihood of a cure for early hepatitis C virus (HCV) infection in people with HIV, according to study findings published in the May 2, 2012, advance online edition of AIDS.

If detected and treated during the acute or early stages of HCV infection, overall sustained response rates are very high with pegylated interferon alone. But HIV positive people typically do not respond as well to interferon and may need more intensive treatment for acute hepatitis C. Ribavirin is known to reduce the risk of post-treatment relapse and therefore raise the odds of a cure.


No comments:

Post a Comment